Animal models of restless legs syndrome

Sleep Medicine

Volumn 8, Issue 4, 2007, Pages 344-348

  Ondo, W G ^a   Zhao, H R ^a   Le, W D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Restless legs syndrome

Indexed keywords

DOPAMINE 3 RECEPTOR; IRON;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; DIENCEPHALON; DOPAMINERGIC SYSTEM; IRON STORAGE; KNOCKOUT MOUSE; LIMB MOVEMENT; MOUSE; NERVE TRACT; NONHUMAN; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RESTLESS LEGS SYNDROME; RODENT; SLEEP; SPINAL CORD;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTROMYOGRAPHY; LOCOMOTION; MICE; MICE, KNOCKOUT; RECEPTORS, DOPAMINE D3; RESTLESS LEGS SYNDROME; SLEEP, REM;

EID: 34248182535     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2007.03.010     Document Type: Article

References (39)

1. Phillips B., Young T., Finn L., Asher K., Hening W.A., and Purvis C. Epidemiology of restless legs syndrome in adults. Arch Intern Med 160 (2000) 2137-2147
2. Ulfberg J., Nystrom B., Carter N., and Edling C. Prevalence of restless legs syndrome among men aged 18-64 years: An association with somatic disease and neuropsychiatric symptoms. Mov Disord 16 (2001) 1159-1163
3. Haskovec L. Akathisia. Arch Bohemes Med Clin 3 (1902) 193-200
4. Allen R.P., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 4 (2003) 101-109
5. Chesson A.L., Wise M., Davila D., Johnson S., Littner M., Anderson W.M., et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. Sleep 22 (1999) 962-968
6. Hening W., Allen R., Earley C., Kushida C., Picchietti D., and Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 22 (1999) 970-999
7. Ondo W.G., and Jankovic J. Restless legs syndrome. In: Appel S.H. (Ed). Current Neurology (1997), IOS Press, Amsterdam 207-236
8. Trenkwalder C., et al. Positron emission tomographic studies in restless legs syndrome. Mov Disord 14 (1999) 141-145
9. Turjanski N., Lees A.J., and Brooks D.J. Striatal dopaminergic function in restless legs syndrome:18F-dopa and 11C-raclopride PET studies. Neurology 127 (1999) 2282-2288
10. Earley C.J., Connor J.R., Beard J.L., Malecki E.A., Epstein D.K., and Alllen R.P. Abnormalities in CSF concentrations of ferritin and transferring in restless legs syndrome. Neurology 54 (2000) 1698-1700
11. Connor J.R., Boyer P.J., Menzies B.S., Dellinger B., Allen R.P., Ondo W.G., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61 (2003) 304-309
12. Mizuno S., Mihara T., Miyaoka T., Inagaki T., and Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 14 (2005) 43-47
13. Earley C.J., Connor J.R., Beard J.L., Malecki E.A., Epstein D.K., and Allen R.P. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54 (2000) 1698-1700
14. Skagerberg G., and Lindvall O. Organization of diencephalic neurons projecting to the spinal cord in the rat. Brain Res 342 (1985) 340-351
15. Takado M., Li Z.K., and Hattori T. Single thalamic dopaminergic neurons project to both theneocortex and spinal cord. Brain Res 455 (1988) 346-352
16. Ondo W.G., He Y., Rajasekaran S., and Le W.D. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome?. Mov Disord 15 (2000) 154-158
17. Qu S., Ondo W.G., Zhang X., Xie W.J., Pan T.H., and Le W.D. Projections of diencephalic dopamine neurons into the spinal cord in mice. Exp Brain Res 168 (2006) 152-156
18. Allen R.P., and Earley C.J. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 18 (2001) 128-147
19. Pittock S.J., Parrett T., Adler C.H., Parisi J.E., Dickson D.W., and Ahlskog J.E. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord 19 (2004) 695-699
20. Ben-Shachar D., Finberg J.P., and Youdim M.B. Effect of iron chelators on dopamine D2 receptors. J Neurochem 45 (1985) 999-1005
21. Chen Q., Beard J.L., and Jones B.C. Abnormal rat brain monoamine metabolism in iron deficiency anemia. J Nutr Biochem 6 (1995) 486-493
22. Qu S, Le W, Zhang X, Xie W, Zhang A, Ondo WG. Locomotion is increased in A11 lesioned mice with iron deprivation: A possible animal model for restless legs syndrome. J Neuropath Exp Neurol 2007 (in press).
23. Zhao H., Pan T., Xie W., Zhang A., Ondo W.G., and Le W. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res 85 (2007) 1065-1076
24. Youdim M.B., Ashkenazi R., Ben-shachar D., and Yehuda S. Modulation of dopamine receptor in the striatum by iron: behavioral and biochemical correlates. Adv Neurol 40 (1984) 159-170
25. Glover J., and Jacobs A. Activity pattern of iron-deficient rats. Br Med J 2 (1972) 627-628
26. Dean Jr. T., Allen R.P., O'Donnell C.P., and Earley C.J. The effects of dietary iron deprivation on murine circadian sleep architecture. Sleep Med 7 8 (2006) 634-640
27. Moore R.Y. Entrainment pathways and the functional organization of the circadian system. Prog Brain Res 111 (1996) 103-119
28. LeSauter J., and Silver R. Output signals of the SCN. Chronobiol Int 15 (1998) 535-550
29. Reuss S. Components and connections of the circadian timing system in mammals. Cell Tissue Res 285 (1996) 353-378
30. Abrahamson E.E., and Moore R.Y. Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res 916 (2001) 172-191
31. Levant B., and McCarson K.E. D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function. Neurosci Lett 303 (2001) 9-12
32. Ali N.J., Davies R.J., Fleetham J.A., and Stradling J.R. Periodic movements of the legs during sleep associated with rises in systemic blood pressure. Sleep 14 (1991) 163-165
33. Espinar S.J., Vela B.A., and Luque O.M. Periodic leg movements in sleep in essential hypertension. Psychiatry Clin Neurosci 51 (1997) 103-107
34. Montplaisir J., Boucher S., Poirier G., Lavigne G., Lapierre O., and Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 12 (1997) 61-65
35. Baier P.C., Winkelmann J., Höhne A., Lancel M., and Trenkwalder C. Assessment of spontaneously occurring periodic limb movements in sleep in the rat. J Neurol Sci 198 (2002) 71-77
36. Lancel M., Mathias S., Faulhaber J., and Schiffelholz T. Effect of interleukin-1 beta on EEG power density during sleep depends on circadian phase. Am J Physiol 270 (1996) R830-R837
37. Neckelmann D., and Ursin R. Sleep stages and EEG power spectrum in relation to acoustical stimulus arousal threshold in the rat. Sleep 165 (1993) 467
38. Lancel M., and Langebartels A. Gamma-aminobutyric Acid(A) (GABA(A)) agonist 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol persistently increases sleep maintenance and intensity during chronic administration to rats. J Pharmacol Exp Ther 293 (2000) 1084-1090
39. Force A.T. Recording and scoring leg movements. Sleep 16 (1993) 748-759